Mitochondrial dysfunction affects cellular energy metabolism, but less is known about the consequences for cytoplasmic biosynthetic reactions. We report that mtDNA replication disorders caused by TWINKLE mutations-mitochondrial myopathy (MM) and infantile onset spinocerebellar ataxia (IOSCA)-remodel cellular dNTP pools in mice. MM muscle shows tissue-specific induction of the mitochondrial folate cycle, purine metabolism, and imbalanced and increased dNTP pools, consistent with progressive mtDNA mutagenesis. IOSCA-TWINKLE is predicted to hydrolyze dNTPs, consistent with low dNTP pools and mtDNA depletion in the disease. MM muscle also modifies the cytoplasmic one-carbon cycle, transsulfuration, and methylation, as well as increases glucose uptake and its utilization for de novo serine and glutathione biosynthesis. Our evidence indicates that the mitochondrial replication machinery communicates with cytoplasmic dNTP pools and that upregulation of glutathione synthesis through glucose-driven de novo serine biosynthesis contributes to the metabolic stress response. These results are important for disorders with primary or secondary mtDNA instability and offer targets for metabolic therapy.
In Brief
Nikkanen et al. report that mtDNA replication defects induce a cellautonomous metabolic stress response in mice, with a widespread imbalance of folate-dependent biosynthetic pathways, including mutagenic dNTP pools, upregulated de novo serine and glutathione synthesis, and deficient metabolite methylation. One-carbon metabolic remodeling is also observed in human patients.
INTRODUCTION
Mitochondria are versatile organelles that participate in cellular catabolic and anabolic pathways. Upon increased energy demand or fasting, they efficiently burn nutrients to synthesize ATP, whereas, in a fed state, they provide cofactors and metabolites for cell growth. The metabolic shifts and the downstream biosynthetic pathways are tightly regulated by the redox status, which changes depending on nutrient availability and mitochondrial function (Nunnari and Suomalainen, 2012) . However, little is known about the consequences of mitochondrial pathology for cytoplasmic biosynthetic pathways.
Mitochondrial disorders are caused by defects in either mtDNA encoding 13 proteins of oxidative phosphorylation or, in $1,300 nuclear genes, encoding mitochondrion-targeted proteins (Pagliarini et al., 2008; Pagliarini and Rutter, 2013) . The disorders show exceptionally variable phenotypes ranging from infantile multi-tissue disorders to adult-onset progressive degeneration of the heart, muscle, brain, or sensory organs. Even mutations in a single gene can cause distinct manifestations, implicating considerable functional complexity of mitochondrial proteins (Hakonen et al., 2005; Naviaux et al., 1999; Van Goethem et al., 2004) . Dominant mutations of TWINKLE, the replicative mtDNA helicase (Korhonen et al., 2004; Spelbrink et al., 2001) , manifest as adult-onset mitochondrial myopathy (MM) (also called progressive external ophthalmoplegia [PEO] ) with multiple mtDNA deletions in post-mitotic tissues (Suomalainen et al., 1992; Zeviani et al., 1989) , whereas recessive mutations of TWINKLE (Nikali et al., 2005) cause mtDNA depletion in the brain and liver (Hakonen et al., 2008) , manifesting as (A) Schematic of the mitochondrial and cytoplasmic folate cycle and summary of findings in Deletor muscle. Red text, increased amount; green, decreased amount of metabolites/cofactors/proteins in Deletor muscle. PSPH, phosphoserine phosphatase; dTMP, deoxy thymidine monophosphate; 3-PG, 3-phosphoglycerate; 3-POHPyr, 3-phosphohydroxypyruvate; PSer, phosphoserine; fMet, formylmethionine; OXPHOS, oxidative phosphorylation; NADH, NAD+, nicotinamide adenine dinucleotide; PHGDH, phosphoglycerate dehydrogenase; PSAT1, phosphoserine aminotransferase; THF, tetrahydrofolate; MTHFD, methylene-tetrahydrofolate dehydrogenase. (B and C) MTHFD2 (B) and MTHFD1L (C) protein amounts in skeletal muscle. Shown are western blot analyses of Deletor and wild-type (WT) mice. Respiratory chain complex II (70-kDa subunit) served as a loading control for mitochondrial protein.
(D and E) mRNA expression levels of Mthfd2 and the serine de novo biosynthesis enzymes Phgdh and Psat1 in skeletal muscle (D) and heart (E) (n = 6). (F) Serine and glycine concentrations in skeletal muscle (WT, n = 10; Deletor, n = 9) and heart (WT, n = 7; Deletor, n = 8). Ultra performance liquid chromatography and triple-quadrupole mass spectrometry were used. (G) In vivo glucose uptake by mouse tissues as determined by [ 18 F]fluoro-2-deoxy-D-glucose labeling and positron emission tomography. The arrow indicates the [ 18 F]FDG signal in the kidney, the arrowhead that in the heart, and the asterisk that in the quadriceps femoris muscle. Right: signal quantification (WT, n = 6; Deletor, n = 5). (H) Folate intermediate concentrations in skeletal muscle (male; WT, n = 5; Deletor, n = 6) were determined by UPLC-MS/MS analysis (except formate) of tissue extracts. Formate concentration (WT n = 5, Deletor n = 9) was determined by gas chromatography-mass spectrometry analysis.
(legend continued on next page) infantile onset spinocerebellar ataxia (IOSCA; progressive cerebellar ataxia, peripheral and optic neuropathy, hearing loss, athetosis, female hypergonadotropic hypogonadism, epilepsy, and hepatopathy), but no muscle symptoms or signs (Lö nnqvist et al., 1998) . The molecular mechanistic basis of the tissue specificity of mtDNA maintenance disorders is unknown.
The ''Deletor'' mouse is a model for adult-onset MM with multiple mtDNA deletions (Tyynismaa et al., 2005) . These mice carry a dominant TWINKLE defect, homologous to a patient mutation that induced a widespread transcriptional response of genes with an amino acid response element in their upstream regulatory region (Tyynismaa et al., 2010) . One of these transcripts was methylenetetrahydrofolate dehydrogenase 2 (Mthfd2), a bi-functional enzyme of mitochondrial folate metabolism (Di Pietro et al., 2004) . The folate cycle, operating in mitochondria and cytoplasm, shuttles one-carbon (1C) units to 1C-dependent biosynthetic pathways, including nucleotide synthesis and methylation reactions (Christensen and MacKenzie, 2006; Jain et al., 2012; Nilsson et al., 2014) . Distinct folates feed separate biosynthetic pathways that compete for a limiting common cofactor pool (Schirch and Strong, 1989; Scott and Weir, 1981; Strong et al., 1990; Suh et al., 2001) . The strong induction of Mthfd2 in Deletor mice raised the question of whether 1C-dependent metabolism could contribute to the pathogenesis of mitochondrial disorders.
Here we report that mtDNA maintenance disease results in whole cellular nucleotide imbalance. This is associated with widespread changes in cytoplasmic anabolic pathways, with highly induced de novo serine biosynthesis, glutathione synthesis, transsulfuration, and a concomitant aberrant methyl cycle with deficient metabolite methylation. Our evidence suggests that remodeling of 1C metabolism is a likely contributor to mtDNA maintenance disease progression, characterized by mtDNA mutagenesis and/or depletion. The cell-autonomous aberration of biosynthetic pathways as a consequence of mtDNA instability implies that the mechanisms also have relevance for conditions with secondary mtDNA instability, such as Parkinson's disease and aging.
RESULTS

Mitochondrial Myopathy Induces Mitochondrial 1C Metabolism and Serine Biosynthesis
We have previously reported the induction of an amino acid starvation response in the Deletor mouse muscle, including prominent induction of MTHFD2, correlating with disease severity (Tyynismaa et al., 2010) . MTHFD2 is expressed at low levels in post-mitotic tissues of healthy adults, which suggested a role for the mitochondrial folate cycle compartment in mitochondrial disease. The cycle produces formyl-methionine for mitochondrial translation, nicotinamide adenine dinucleotide phosphate (NADPH) for membrane synthesis, and formate, which is the major 1C donor for cytoplasmic purine synthesis ( Figure 1A ; Tibbetts and Appling, 2010). We show here that two key enzymes of the mitochondrial 1C cycle, MTHFD2 and MTHFD1L, were induced in the Deletor muscle, but no change in Shmt2 gene expression was detected (Figures 1B-1E ; Figure S1A ). Serine is the primary 1C donor for the mitochondrial folate cycle, donating its side-chain carbon to folate, which generates glycine and methylene-tetrahydrofolate, entering the 1C cycle. Serine can be imported to cells from extracellular sources or made de novo by diverting 3-phosphoglycerate from the glycolytic pathway to the 1C cycle by phosphoglycerate dehydrogenase (PHGDH) (Locasale et al., 2011) . We found both serine and glycine concentrations to be increased 1.5-to 2-fold in Deletor muscle and heart (Figure 1F) , with 5-to 10-fold increased gene expression of enzymes of the de novo serine biosynthesis pathway, PHGDH and phosphoserine aminotransferase (PSAT1) (Figures 1D and 1E) . Also, the in vivo uptake of glucose (2-[ , the primary substrate of de novo serine biosynthesis, was high in Deletor skeletal muscle and heart ( Figure 1G ). We found no signs of increased serine in Deletor liver and brain (Figure S1B) . These data indicate a strong induction of the mitochondrial compartment of the 1C cycle specifically in the affected tissues in mtDNA maintenance disease.
Mitochondrial and Cytoplasmic 1C Cycle Imbalance in Mitochondrial Disease
To understand whether the remarkable induction of mitochondrial folate cycle enzymes affected the total cellular folate pools, we established a mass spectrometric analysis for specific folate intermediates that serve different biosynthetic reactions (Figure 1H ; Figure S1C ). Different tetrahydrofolate (THF) intermediates showed significant increases in male Deletor muscle (Figure 1H) , and similar but more subtle changes were present in female Deletors, which showed a slightly slower progression of MM disease than males (Tyynismaa et al., 2010) . In males, formate, the product of MTHFD1L and substrate for purine synthesis, was 30% that of the wild-type (WT) level, but THF forms showed induction, with increased 5-methyl-THF, 5,10-methylene-THF, and THF amounts. In female Deletors, 5-methyl-THF, which is the cofactor donating 1C units for methylation reactions, and 5,10-methenyl-THF, produced by MTHFD2 and regulating 1C flow toward purine metabolism (Field et al., 2006) , were elevated 1.5-fold ( Figure S1C ). These findings indicate a remarkable steady-state imbalance of folate cycle intermediates and are consistent with the increased demand of 1C units for purine and methionine synthesis in mtDNA replication disease.
Folinic Acid Supplementation Does Not Reverse Disease Pathology
The marked upregulation of the mitochondrial folate cycle as well as the imbalance of whole cellular folate species raised the question of whether folate supplementation would be beneficial for (I) Folinic acid (Fol) supplementation effects. Shown is the 5-and 10-formyl-THF level in skeletal muscle of WT and Deletor mice after 8-week supplementation with folinic acid (n = 5 mice/group). (J and K) Folinic acid supplementation effects and mRNA expression. Mthfd2 (J) and Fgf21 (K) in Deletor skeletal muscle after 8-week supplementation (n = 5 mice/group, qPCR). (L and M) mtDNA deletion load (L) and number of COX-deficient muscle fibers (M) after folinic acid supplementation (n = 5 mice/group). All data are presented as mean, and error bars indicates SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S1 . disease pathology. We supplemented 22-month-old Deletors with advanced disease and their WT littermates with folinic acid (5-formyl-THF), the active storage folate form. Eight weeks of supplementation significantly increased the 5-formyl-THF concentration 6-fold in Deletor muscle, whereas, in the WT, the amount increased 2-fold. The increase indicated successful and enhanced delivery of the compound to the affected tissue ( Figure 1I ). However, the increased cofactor availability did not affect disease-associated changes (Mthfd2, Fgf21 expression levels, mutant mtDNA amount, and cytochrome c oxidase (COX)-negative fibers; Figures 1J-1M ). These data indicate that the pathology-associated folate cycle changes are not improved by nutritional folate availability.
The Metabolome of mtDNA Maintenance Disease Indicates an Alternative 1C Donor and Purine Biosynthesis Induction The aberrant cytoplasmic and mitochondrial folate cycle predicted changes in the major biosynthetic pathways, purine synthesis, methyl cycle, and transsulfuration (Figure 2A ), sharing the limited 1C pool. This prompted us to undertake a highthroughput quantitative analysis of 109 metabolites of Deletor Tables S2 and S3 . (E) Amino acid levels in Deletor muscle (Deletor, n = 8; WT, n = 7). (F) Purine metabolites changed significantly in the heart (Deletor, n = 8; WT, n = 7). (G) Hypoxanthine amount in Deletor muscle (Deletor, n = 9; WT, n = 10). (H) dNTP concentrations in skeletal muscle (Deletor, n = 5; WT, n = 8).
(I) Unmethylated metabolites of creatine and phosphatidylcholine synthesis (guanidino-acetic acid, phosphatidylethanolamine). All data are presented as mean, and error bars indicate SEM. *p < 0.05, **p < 0.01. See also Figure S2 ; Tables S1, S2, and S3. muscle and heart (Table S1 ). Unsupervised clustering indicated genotype-specific clustering ( Figure 2B ). The altered metabolites indicated a widespread increase of amino acid concentrations, especially serine and glycine, which are known cellular donors of 1C units. Elevated concentrations of threonine and betaine, which indirectly connect to folate and methyl cycles, suggest the induction of alternative 1C sources to replenish the 1C pool (Figures 2C-2E ). In the Deletor heart, the purine degradation products adenosine, guanosine, inosine, and xanthosine were especially increased (1.5-to 3-fold; Figure 2F ), and more modest but significant changes of hypoxanthine were present in Deletor skeletal muscle ( Figure 2G ). These findings strongly suggest that a primary mtDNA replication defect modified a major cytoplasmic anabolic pathway, purine metabolism.
mtDNA Maintenance Defects Disturb dNTP Pools
Because of the steady-state purine metabolic aberrations and because pyrimidines were not well represented in our targeted metabolomics screening, we directly measured whole cellular deoxynucleotide triphosphate (dNTP) pools, the end products of purine and pyrimidine synthesis, in Deletor skeletal muscle. The pools were remarkably increased and imbalanced, with deoxyadenosine triphosphate (dATP) showing 3-fold, deoxythymidine triphosphate (dTTP) and deoxycytidine triphosphate (dCTP) 2-fold, and deoxyguanosine triphosphate (dGTP) 1.3-fold increased concentrations compared with WT littermates (Figure 2H ). Imbalanced and increased dNTP pools are well known to be genotoxic in dividing cells (Garcia-Diaz et al., 2014) . mtDNA replication is the major user of cytoplasmic dNTPs in post-mitotic tissues (Bourdon et al., 2007) , and imbalanced dNTP pools would therefore primarily induce mtDNA mutagenesis. Deletor mice show progressive mutagenesis as multiple mtDNA deletions accumulate in their skeletal muscle and heart ( Figure S2A ), along with the disease progression in mice and patients. Our next-generation mtDNA sequencing analysis of Deletor muscle did not indicate an increased mtDNA point mutation rate ( Figure S2B ), which may be explained by the high fidelity of the mtDNA polymerase, with an accurate exonuclease function. These results are consistent with altered dNTP pools accelerating mtDNA mutagenesis in disorders with multiple mtDNA deletions.
mtDNA Maintenance Defects Lead to Insufficient Metabolite Methylation
The folate cycle also feeds the methyl cycle, a major 1C-dependent biosynthetic pathway, accepting 1C units from 5-methyl-THF for methionine synthesis. The methylation capacity is especially used for metabolite methylation, of which creatine and phosphatidylcholine (PC) synthesis utilizes the vast majorityup to 80%. Creatine synthesis occurs when guanidinoacetate methyltransferase (GAMT) methylates guanidino-acetic acid (GAA) in an S-adenosylmethionine (SAM)-dependent reaction (García-Martínez and Appling, 1993; Pike et al., 2010) , and PC synthesis involves the methylation of phosphatidylethanolamine (PE). To find out whether the methyl cycle was affected by the imbalanced folate pools, we analyzed both creatine and PC synthesis. The precursors of both were increased in Deletor muscle: GAA +1.5-fold and PE +1.7-fold ( Figure 2I ). No major changes in total genomic DNA methylation, a minor user of the methyl pool, were present in Deletor muscle (p = 0.44). These results strongly point to an aberrant methyl cycle and insufficient methylation capacity for creatine and PC synthesis in skeletal muscle, the major site of creatine synthesis in adult age, upon mtDNA replication disease.
[U-
C]-Glucose Flux toward De Novo Synthesis of Serine and Glutathione in Deletor Mice
The considerable changes in steady-state de novo serine biosynthesis and 1C-dependent pathways in mitochondrial disease raised the question of the direction of metabolic flux. First we established that Deletor heart and skeletal muscle showed increased [ 18 F]FDG uptake, measured by PET/ CT analysis (Figure 1G) . To directly assess the metabolic flux in vivo, we administered uniformly [U-
13 C]-labeled glucose to Deletor and WT mouse tail veins and followed the primary biosynthetic incorporation of glucose-derived carbons into downstream metabolites. Because of the prominent upregulation of the serine de novo biosynthesis pathway, we chose the chase time point of 15 min, during which serine labeling was in the linear phase (Figure S3A ). The Deletor heart showed the most significant changes, although, at the specific time point, the skeletal muscle labeling was not yet significant. Oxidative metabolism of the fully labeled glucose resulted in fully [U-13 C]-labeled serine (three carbons, m+3), the amount of which was increased 2-fold compared with WT mice ( Figure 3A) . Glutathione (m+5) labeling was also increased $2-fold compared with the WT. The glutathione m+5-labeled carbons originate from glucose-derived serine and glycine as well as glutamate. The specific glucose carbons from serine versus glutamate could not be traced, but the overall significant glutathione labeling demonstrates increased glutathione biosynthesis.
Serine is a substrate for cystathionine synthesis in transsulfuration ( Figure 3B ). We found increased steady-state levels of cystathionine and g-glutamylcysteine in the heart, and cystathionine g-lyase (CTH) was highly induced in Deletor heart and muscle ( Figures 3C and 3D) . Also, glutamate-cysteine ligase (GCLC) showed increased expression ( Figure 3F ; Figure S3B ) in muscle, which agrees with an increased need of glutathione and flux toward its synthesis upon mtDNA replication defects. Also, glutathione reductase activity was increased, but no change was detected in glutathione peroxidase activity ( Figure 3G ). This serineglutathione pathway is highly conserved in species. Analysis with the Clustering of Inferred Models of Evolution (CLIME) program (Li et al., 2014) revealed that PHGDH (the rate-limiting enzyme in de novo serine biosynthesis) closely co-evolved with CTH and cystathionine b-synthase (CBS), the first two enzymes in the transsulfuration pathway ( Figures 3B and 3E) , which strongly supports a functional interdependence of the pathways.
These data show that mitochondrial dysfunction induces a potential stress pathway in the affected tissues, promoting glucose-driven de novo serine biosynthesis and directing serine to the transsulfuration pathway to synthesize glutathione.
The Recessive TWINKLE Disease Model for IOSCA Shows Aberrant, Low Muscle dNTP Pools
To analyze whether the metabolic changes found in Deletor mice have a role in another model of mtDNA maintenance disease, we generated a mouse model for IOSCA disease, also caused by TWINKLE mutation, but being recessive and causing a severe infantile disease with partial loss of mtDNA, i.e., mtDNA depletion. We inserted a c.1526 A > G mutation in exon 3 of the C10orf2 gene (p.Y508C in human IOSCA patients and p.Y509C in mice) encoding the TWINKLE helicase ( Figures 4A-4C ). The different genotypes were born in Mendelian proportions. Homozygous IOSCA knockin mice (''IOSCA mice'') had decreased mtDNA copy numbers in the liver, but no depletion was detected in other tissues ( Figure 4D ), and no mtDNA deletions were detected (Figure 4E ). At 17 months of age, IOSCA mice consumed more oxygen and produced more CO 2 at thermoneutral temperature (+30 C) compared with their WT littermates ( Figure 4F ). IOSCA mice weighed less than WT mice from 9 months of age (Figure 4G) but showed no apparent motor or sensory defects (Figures S4A and S4B) . At 6 months of age, 5 of 21 male mice manifested with generalized epileptic seizures induced by handling (Movie S1). Despite the relatively subtle neurological phenotype of the IOSCA mice, their brains showed clear signs of progressive neurodegeneration at 19 months of age. The hippocampal pyramidal neuron layer in the CA1 region showed decreased neurite density and disorganization of the apical dendritic trees ( Figures 4H-4J ) without a reduction in neuronal number. Other hippocampal regions, deep gray matter nuclei, and cortical neurons showed no changes. Deletor mice (24 months old) had a WT-like cerebellar and hippocampal CA1 neuronal morphology ( Figures 4H and 4J) . The cerebellar Purkinje neurons of IOSCA mice were decreased in number and showed reduced arborization of the dendritic trees ( Figure 4T ). These results indicate that cerebellar Purkinje cells were most sensitive to IOSCA mutation, followed by the large neurons of hippocampal CA1, a region implicated in epilepsy. The Purkinje cell changes were not severe enough to manifest as ataxia. Similar to IOSCA patients (Figure S4C) , the skeletal muscle of IOSCA mice lacked signs of MM, whereas Deletor mice and MM/PEO patients harbored COX-deficient muscle fibers (Figures 4K-4M ; Figure S4D ). IOSCA mouse hepatocytes showed degenerative vacuolization indicative of hepatopathy ( Figures 4N-4P ) and decreased lipid content. Deletor livers also had reduced lipids but no degeneration ( Figures 4Q-4S ). Fibroblast growth factor 21, secreted by Antibodies used were as follows: calbindin (red in the overlay) indicates Purkinje neurons; respiratory chain complex II (70-kDa subunit) indicates mitochondria (green in overlay). Nuclear DAPI counter staining was performed (blue in the overlay). Paraffin sections were used. The arrow indicates Purkinje cell dropout. Scale bars, 100 mm. All data are presented as mean, and error bars indicate SEM. *p < 0.05, **p < 0.01. See also Figure S4 and Movie S1. respiratory chain-deficient muscle fibers of Deletor mice, was not induced in IOSCA mice ( Figure S4E ). These results show that IOSCA mice manifest a mitochondrial epileptic encephalohepatopathy replicating the key findings of IOSCA patients.
IOSCA mouse muscle showed significant but opposite metabolite findings compared with Deletors, including low amino acid levels ( Figure 5A ). Furthermore, IOSCA mouse muscle showed a dNTP pool imbalance with generally decreased concentrations of all dNTPs ( Figure 5B ). The findings in the Deletor and IOSCA mouse muscles suggest that TWINKLE-associated mtDNA maintenance disorders have genotype-specific effects on dNTP pools and that these changes contribute to the mtDNA findings in the disease: multiple mtDNA mutations in MM and mtDNA depletion in IOSCA.
Homology Modeling of Human TWINKLE with Mutations
Causing IOSCA and MM To understand the mechanism of how different TWINKLE mutations have opposite effects on dNTP pools, we performed homology modeling. We utilized the structure and analysis of a close TWINKLE homolog, T7 gene 4 ring helicase, with its subunits trapped in different catalytic steps (PDB ID 1E0J) (Figure 5C (C) Protein modeling of human WT TWINKLE helicase based on the structure of T7 gene 4 helicase (PDB ID 1E0J). Y508 is shown in purple. Three neighboring subunits (A-C) of human TWINKLE are modeled in sequential catalytic steps. Intrasubunit interactions and their changes within helicase domain couple NTP (red) hydrolysis with ssDNA translocation. As in bacteriophage helicase, ssDNA is bound to only one subunit in the hexamer at the time, and, therefore, each subunit sequentially undergoes the same cycle of catalytic events. Left: catalysis initiation with NTP binding, triggering binding of DNA. Center: DNA initiates NTP hydrolysis, followed by (right) nucleotide diphosphate (NDP) and phosphate (Pi) release and subunit rotation, needed for ssDNA translocation through the central pore of the helicase. Coupling of NTP hydrolysis and DNA movement is maintained by rearrangement of non-covalent bonding in the hydrophobic core of the helicase domain (pink dashed lines). Y508 (pink) is involved in the coupling mechanism. Note the important stacking interaction between Y484 and Y508 in the WT undergoing on/off modes upon the catalytic cycle, driven by ssDNA binding/translocation. (D) Modeling of TWINKLE helicase with IOSCA amino acid change (Y508C in human and Y509C in mouse). The variant is predicted to modify hydrophobic interactions within the helicase domain, keeping it in an intermediate state between ''loose'' and ''empty.'' We propose that this flexible conformation is favoring fast DNA-independent NTP hydrolysis and product release. (E) Model of the pathogenic consequences of dominant TWINKLE mutation underlying mitochondrial myopathy. Mutant helicase leads to replication stalling, potentially because of immature TWINKLE detachment from the DNA template. The stalling replisome induces DNA breaks, which elicits the mtDNA replication stress response, with induced serine and glutathione biosynthesis promoting dNTP synthesis. (F) Model of the pathogenic consequences of the recessive TWINKLE mutation underlying IOSCA and infantile encephalohepatopathy. The mutation disturbs coupling of NTP binding and ssDNA, leading to NTP hydrolysis by TWINKLE without bound ssDNA. NTP hydrolysis without DNA binding depletes cells of dNTPs, resulting in mtDNA depletion specifically in post-mitotic tissues, with a low dNTP pool mostly serving mtDNA maintenance. All data are presented as mean, and error bars indicate SEM. *p < 0.05, **p < 0.01, ***p < 0.001, **** < 0.0001. See also Figure S5. one subunit in the hexamer at a time and, therefore, that the catalytic events of the helicase are sequential: NTP binding triggers ssDNA binding via specific loops of the same subunit, structural changes caused by the bound ssDNA initiate NTP hydrolysis, and DNA-binding loops move and translocate the ssDNA through the central pore of the helicase as proposed for the T7 helicase. The sequential mode and cooperation of the different subunits within the helicase ring rely on ssDNA binding, NTP hydrolysis, and the structure of the NTP binding site, which locates on the interface between two neighboring subunits, but only one of these subunits provides the main contacts for nucleotide binding (Singleton et al., 2000) . NTP hydrolysis and ssDNA translocation by one subunit are accompanied by structural rearrangements in the NTP binding site as well as rotation of the subunit in the plane of the ring, which initiate the same sequence of catalytic events in the neighboring subunit. Without bound ssDNA, a hexamer can hydrolyze NTPs non-sequentially and is therefore very slow because of the lack of bound ssDNA propagation of the structural changes around the helicase ring (Crampton et al., 2006; Liao et al., 2005) .
We mapped the IOSCA mutation on the attained TWINKLE helicase structure model and performed a comparative analysis of the corresponding part of the structure in T7 gene 4 ring helicase. The analysis predicted that the Y508C mutation affects the coupling between NTP hydrolysis and ssDNA binding/translocation, resulting in ssDNA-independent NTP hydrolysis ( Figure 5D ). Therefore, IOSCA mutation switches TWINKLE to the idling mode when NTP is hydrolyzed without DNA binding or unwinding. These results are consistent with previous findings of an increased NTP hydrolysis rate of recombinant IOSCA-TWINKLE protein (Hakonen et al., 2008) , mtDNA depletion in IOSCA patients, as well as decreased dNTP pools identified in IOSCA mouse muscle.
The 13-amino-acid TWINKLE duplication, present in Deletor mice and in PEO patients, locates in the linker between the C-terminal helicase and N-terminal domain. This dominant mutation, coexisting in MM with WT subunits, extends the linker but does not affect the interaction between the subunits ( Figure S5A ). We predict that, upon MM mutation, the strain created on the subunit interface upon its rotation during catalysis leads to progressive accumulation of physical tension within the hexamer upon consecutive DNA unwinding cycles and induces the helicase to detach from the template, causing mtDNA replication stress and fork stalling, as has been shown to occur in Deletor muscle (Goffart et al., 2009) .
These modeling data propose that IOSCA TWINKLE binds to DNA relatively rarely because NTP hydrolysis is ssDNA-independent in the mutant, but when the binding occurs, the mutant helicase will complete unwinding of the entire molecule. This might explain mtDNA depletion without deletions in affected tissues of IOSCA patients and in the mouse model. Furthermore, the continuous hydrolysis of NTP is likely to affect mitochondrial dNTP pools.
IOSCA and MM/PEO Patients Show Signs of 1C Metabolic Remodeling
To clarify whether a 1C imbalance also occurs in human patients, we were able to obtain blood and muscle from MM patients and blood from IOSCA patients with matched controls and performed a 100-metabolite analysis. Both patient groups showed genotype-specific metabolite fingerprints ( Figure 6A ) and shared metabolite patterns with the mice. Cystathionine, serine, and glutamic acid were among the eight metabolites changed significantly in all patient samples (Figures 6B-6F) , and the main end products of transsulfuration, glutathione and taurine, were decreased in IOSCA blood ( Figure 6B ). IOSCA patients showed evidence of disturbed GAA/creatine metabolism (creatine:creatinine ratio fold change [FC] +2.9, p = 0.008) ( Figure S6A ). Of the purine metabolites, adenosine was decreased 7.6-fold in IOSCA compared with controls (p = 0.03). In PEO blood, intermediates of purine synthesis and catabolism (xanthine FC +1.5, p = 0.0009; inosine monophosphate [IMP] FC +1.4, p = 0.012; xanthosine FC +1.5, p = 0.017) as well as the alternative 1C donors betaine (FC +1.5, p = 0.001) and dimethylglycine (FC +1.6, p = 0.002) were changed significantly. These changes supported aberrations of transsulfuration and purine metabolism in both patient groups and creatine synthesis in IOSCA. Specific for the PEO patient muscle, acylcarnitines were increased, which suggested decreased utilization of fatty acids and accumulation of toxic fatty acid intermediates ( Figure 6E ).
DISCUSSION
The outstanding question in the mitochondrial disease field is what underlies the wide spectrum of disease manifestations. We designed mouse models for mitochondrial myopathy and IOSCA, both caused by TWINKLE helicase defects, to shed light on the physiological basis of tissue specificity. First, we report here that IOSCA knockin mice replicate the key manifestations of the human recessive IOSCA and Alpers-Huttenlocher syndromes, making these mice the first model for a common manifestation of mitochondrial disease in early childhood: epileptic encephalohepatopathy. Second, we report that primary mtDNA replication disorders modify the cellular serine-glycine-1C metabolism and dNTP pools. Figure 6G summarizes the main metabolic findings in the different tissues of our mice and patients, with major changes in the folate cycle-dependent biosynthetic pathways in the affected tissues.
Our protein modeling proposes that the mechanism in IOSCA involves active NTP hydrolysis by the mutant helicase, whereas, in the case of MM, replication stalling boosts dNTP synthesis. MM defects direct glucose carbons to serine de novo biosynthesis as well as glutathione synthesis, an antioxidant and reductant that, through the glutaredoxin system, also promotes dNTP synthesis (Sengupta and Holmgren, 2014) . This explains why TWINKLE disorders mimic those of primary dNTP pool defects, including diseases caused by ribonucleotide reductase mutations. Severe protein defects result in a lack of dNTPs and consequent mtDNA depletion, whereas adult-manifesting defects involve metabolic remodeling of cellular biosynthesis pathways, the stalled replisome boosting nucleotide synthesis, resulting in aberrant dNTP pools and mtDNA deletion mutagenesis. These changes are limited to affected tissues and cell-autonomous, implying a relevance of our findings to primary and secondary conditions with mtDNA mutagenesis.
The finding of in vivo glucose carbon flux in the affected tissues of MM to serine and glutathione was unexpected. Serine 
(legend continued on next page)
is a non-essential amino acid with multiple crucial roles in cellular metabolism. Its de novo synthesis from glucose is a three-step pathway, deviating a fraction of 3-phosphoglycerate from glycolysis toward serine. However, the role of de novo serine synthesis is not fully understood. We studied the evolutionary history of the rate-limiting enzyme PHGDH and show evidence that PHGDH coevolved with the transsulfuration enzymes CTH and CBS, suggesting that serine de novo synthesis is preserved to support cellular transsulfuration and glutathione synthesis. Recent data have suggested that de novo serine and glutathione synthesis are required for cancer cell proliferation to support the high demand of dNTP synthesis. Downregulation of this pathway has been found to decrease cellular dNTP pools (DeNicola et al., 2015; Mehrmohamadi et al., 2014) . Ribonucleotide reductase utilizes nucleotide precursors, thioredoxin, and active glutaredoxin, which requires glutathione as a hydrogen donor (Sengupta and Holmgren, 2014) . These components were induced in the affected tissues of Deletor mice, strongly supporting the conclusion that TWINKLE dysfunction in mitochondrial myopathy induces serine-directed glutathione synthesis to promote dNTP synthesis, a pathway showing strong conservation in species. Our finding suggests that PHGDH also has the potential to divert intracellular glucose flux toward serine in post-mitotic tissues (Locasale et al., 2011) . We propose that serine de novo biosynthesis is a rapid response in skeletal muscle and heart to cellular metabolic/DNA stress, driving glutathione synthesis to prevent damage and support repair.
In yeast, ribonucleotide reductase determines genomic DNA replication fork speed by modulating dNTP pools, and chromosomal DNA damage induces dNTP synthesis (Poli et al., 2012) . In Deletor mice, TWINKLE dysfunction causes mtDNA replication fork stalling (Goffart et al., 2009) , which could also lead to decreased utilization of dNTPs. However, a stalled fork is a strong inducer of the DNA damage response when it occurs in genomic DNA. Our evidence of an increased dNTP synthesis pathway upon TWINKLE dysfunction suggests the existence of an mtDNA repair response, mimicking that of the nuclear genome. The response was, however, mutation-specific. The IOSCA mutation, not resulting in mtDNA replication stalling (Hakonen et al., 2008) , did not induce serine/glutathione biosynthesis but had low dNTP pools. Our results show that TWINKLE mutations modify dNTP pools, which, together with the facts that TWINKLE is a licensing factor for mtDNA replication (Tyynismaa et al., 2004) and utilizes dNTPs as its fuel (Hingorani and Patel, 1996; Sawaya et al., 1999) , suggests the intriguing possibility that TWINKLE activity synchronizes mtDNA replication with nutrient status and cellular anabolism.
Increased purine and glutathione synthesis could potentially form a carbon sink and increase homocysteine demand, thereby disturbing the methyl cycle. Indeed, we found accumulations of un-methylated precursors of creatine and phosphatidylcholine synthesis, the major users of 1C units in post-mitotic cells, in Deletor muscle. Of the total cellular methylation capacity, 60% is used for creatine synthesis, 30% for PC, and a minor part for protein, RNA, and DNA methylation (Mudd et al., 2007) . Creatine synthesis and folate supply are especially important for the brain in childhood because inborn errors of creatine and folate metabolism manifest as ataxia and severe epilepsy (Stö ckler et al., 1996) . In adults, however, muscle is the primary site of creatine metabolism. It contains over 95% of body creatine, both synthesized on-site and imported (Balsom et al., 1994) . This evidence suggests that the 1C dependence of post-mitotic cell types and tissues varies depending on their maturation state at a given age and time, making the infant brain and adult muscle especially susceptible to 1C metabolic aberrations, liver being the central organ metabolizing THF. Interestingly, a similar dichotomy in clinical manifestations-infantile onset brain/liver versus adult-onset muscle manifestations-is also typical for primary disorders of dNTP metabolism, caused by defects of ribonucleotide reductase 2B and purine-metabolic deoxyguanosine kinase (Bourdon et al., 2007; Mandel et al., 2001) , suggesting that they share a similar pathogenic mechanism. We propose that the tissue specificity of mtDNA maintenance disorders, with severe mutations causing early-onset encephalohepatopathy and milder mutations adult-onset myopathy, is explained by the age-dependent susceptibility for folate-driven cytoplasmic biosynthesis pathways.
Concentrations of the distinct folate species are well below the saturation level of 1C-dependent biosynthetic enzymes (Scott and Weir, 1981; Suh et al., 2001) , making the folate pool a metabolic rheostat. It matches nutrition availability and redox status with the biosynthetic requirements of a tissue in a contextdependent manner. The evidence suggests that a 1C metabolic defect and aberrant dNTP pools contribute to multiple mtDNA deletion formation, which occurs in mitochondrial disease, normal aging, and degenerative diseases such as Parkinson's disease neurons (Bender et al., 2006; Cortopassi et al., 1992) . Indeed, folate supplementation has been reported to ameliorate disease-associated findings in fruit flies and patient cells carrying a mutation in PINK1, a gene underlying inherited Parkinson's disease (Tufi et al., 2014) . In our study, short-term folinic acid supplementation for old Deletor mice was not sufficient to reverse their myopathy, which may be explained by their late-stage disease. However, the folate cycle is tightly regulated by vitamin cofactors and nutrients, offering multiple attractive targets for therapy tailored in a context-and manifestation time-dependent manner.
(C) Common metabolites changed in both PEO and IOSCA blood. Red text indicates an increased level in both patient groups. Succinate increased in PEO and decreased in IOSCA blood. (D-F) Quantification of significantly changed metabolites in IOSCA and PEO blood (D) and PEO muscle (E and F). Red circles, TWINKLE-PEO; red triangles, single mtDNA deletion (PEO patients).
(G) Summary of the main metabolic findings in the different tissues of MM and IOSCA mouse models and human patients. Red, increased; blue, decreased. The size of the font reflects the prominence of the pathway in the specific tissue. GABA, g-aminobutyric acid; TCDCA, taurochenodeoxycholic acid; cAMP, cyclic AMP; ribose-5-P, ribose-5-phosphate; g-Glu-Cys, g-glutamylcysteine; NAD, nicotinamide adenine dinucleotide. All data are presented as mean, and error bars indicates SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.001. See also Figure S6 .
EXPERIMENTAL PROCEDURES
The human materials were collected and used with informed consent according to the Helsinki Declaration and approved by the Ethical Review Board of Helsinki University Central Hospital. The National Animal Experiment Review Board and Regional State Administrative Agency for Southern Finland approved our animal experiments, which were conducted according to the European Union Directive.
Patient Material and Sampling
The following PEO patient blood samples were used: males, n = 4; one female; all with a dominant duplication mutation (p.352-364) in C10ORF2 (TWINKLE) (Suomalainen et al., 1992 (Suomalainen et al., , 1997 ; one male patient carrying two recessive mutations in POLG1 (patient II/11 in Luoma et al., 2004) ; ages, 38-56 years. The following muscle samples were used: samples from three TWINKLE PEO patients and two patients with single large mtDNA deletions. IOSCA patients were homozygous for recessive p.Y508C change (C10ORF2) in TWINKLE helicase (males, n = 3; females, n = 2; age, 31-41 years). Peripheral venous blood samples from the patients were used for metabolic analysis. PEO samples were taken with K 2 -EDTA as an anticoagulant. Plasma was immediately separated, frozen, and stored at À140 C for metabolomic analyses. Serum was used for IOSCA patients.
Animal Models
Deletor mice expressed a dominant in-frame duplication homologous to our human patients' mutation (in mouse p.353-365) as reported previously. Two different transgene lines were used (Tyynismaa et al., 2005 (Tyynismaa et al., , 2010 . Mice overexpressing wild-type TWINKLE showed no pathology (Tyynismaa et al., 2004) . IOSCA mice were generated by introducing a c.1526 A > G mutation into C10orf2 exon 3 by homologous recombination. The resulting mice were crossed with Flp recombinase-expressing C57BL/6 to remove the neomycin (NEO) cassette.
Folinic Acid Supplementation
Deletor mice were supplemented with PBS or 0.28 mg folinic acid (SigmaAldrich, catalog no. F7878) for eight weeks via intraperitoneal injections (first 5 consecutive days and continued twice a week until the end of the study) and via drinking water (0.28 mg/ml) throughout the study. dNTP Pool Measurement Total nucleotides were extracted and analyzed as in Martí et al. (2012) . Briefly, extracts or standards were added to a reaction mixture (40 mM Tris/HCl [pH 7.5], 10 mM MgCl 2 , 5 mM dithiothreitol, 0.25 mM primed oligonucleotide, 0.75 mM 3 H-dTTP or 3 H-dATP, and 0.30 U Taq DNA polymerase in a total of 20 ml) and incubated at 48 C for 60 min. 15 ml of mixture was spotted onto DE-81 filter paper and dried. The filter papers were washed (three times with 5% Na 2 HPO 4 and once with water and 95% ethanol). The radioactivity was quantified by a liquid scintillation counter. We performed three to six measurements for all individual samples.
Protein, RNA, and DNA Immunoblotting was done using the antibodies listed in the Supplemental Experimental Procedures. The mtDNA integrity and amount were analyzed by qRT-PCR as in Khan et al. (2014) . mRNA levels were quantified by qRT-PCR (see Supplemental Experimental Procedures for primers used).
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Statistical Methods
For statistical significance analysis we used unpaired Student's t test unless mentioned otherwise (see Supplemental Experimental Procedures). For outlier analysis we used the GraphPad Prism 6.0 robust regression and outlier removal (ROUT) method (Q = 1%). For false positive analysis in metabolomics we used the Benjamini-Hochberg method with a critical value of 0.2.
Metabolomics Analyses
Metabolomic and folate intermediate analyses were performed using Waters Acquity ultra performance liquid chromatography (UPLC) and triple-quadrupole mass spectrometry analysis. Formate was measured by gas chromatography (GC) MS analysis.
TWINKLE Homology Modeling and Structure Analysis
Homology modeling of the human TWINKLE hexamer was made using the structure of bacteriophage T7 gene 4 helicase-primase with a bound NTP analog (PDB ID 1E0J) (Singleton et al., 2000) . For the sequences of the TWINKLE homologs we used the UniProt database (http://www.uniprot.org), and for alignment we used PROMALS3D (http://prodata.swmed.edu/ promals3d/promals3d.php). For multiple sequence alignment and structure modeling we used the SWISS-MODEL server (http://www.swissmodel. expasy.org) (Arnold et al., 2006 ). The resulting model was analyzed in Accelrys Discovery Studio v4.1 (https://www.csc.fi).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, six figures, three tables, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.cmet.2016.01.019.
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